Fibromyalgia coverage uneven despite recent drug approvals.
Sipkoff
Martin
M
D000700:Analgesics; D000068736:Duloxetine Hydrochloride; D005356:Fibromyalgia / Q000145:classification / Q000188:drug therapy* / Q000503:physiopathology; D006801:Humans; D007356:Insurance, Pharmaceutical Services; D000069583:Pregabalin; D017367:Selective Serotonin Reuptake Inhibitors; D018434:Sickness Impact Profile; D013876:Thiophenes / Q000191:economics* / Q000627:therapeutic use; D014481:United States; D014486:United States Food and Drug Administration; D005680:gamma-Aminobutyric Acid / Q000031:analogs & derivatives* / Q000191:economics / Q000627:therapeutic use
D000700:Analgesics; D000068736:Duloxetine Hydrochloride; D000069583:Pregabalin; D017367:Selective Serotonin Reuptake Inhibitors; D013876:Thiophenes; D005680:gamma-Aminobutyric Acid